{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:27:33Z","timestamp":1791876453471,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nmd.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T02:03:00Z","timestamp":1565316180000},"page":"716-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["241st ENMC international workshop: Towards a European unifying lab for Kennedy's disease. 15\u201317th February, 2019 Hoofddorp, The\u00a0Netherlands"],"prefix":"10.1016","volume":"29","author":[{"given":"L.","family":"Greensmith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Pradat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sorar\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pennuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2019.07.008_bib0001","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ncl.2015.07.002","article-title":"Spinal and bulbar muscular atrophy","volume":"33","author":"Grunseich","year":"2015","journal-title":"Neurol Clin"},{"key":"10.1016\/j.nmd.2019.07.008_bib0002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1212\/WNL.0000000000000434","article-title":"Brugada syndrome in spinal and bulbar muscular atrophy","volume":"82","author":"Araki","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.07.008_bib0003","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jnnp-2015-311305","article-title":"Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients","volume":"87","author":"Querin","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2019.07.008_bib0004","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1212\/WNL.0000000000004748","article-title":"Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy","volume":"89","author":"Guber","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.07.008_bib0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2019.07.008_bib0006","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","article-title":"Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy","volume":"7","author":"Lieberman","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.nmd.2019.07.008_bib0007","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1093\/hmg\/ddv300","article-title":"Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy","volume":"24","author":"Sahashi","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2019.07.008_bib0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2019.07.008_bib0009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1471-4914(02)02332-8","article-title":"Altered acetylation in polyglutamine disease: an opportunity for therapeutic intervention?","volume":"8","author":"Taylor","year":"2002","journal-title":"Trends Molec Med"},{"issue":"4","key":"10.1016\/j.nmd.2019.07.008_bib0010","first-page":"5","article-title":"Pathological mechanisms of polyglutamine diseases","volume":"8","author":"Rinaldi","year":"2015","journal-title":"Nat Educ"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.008_bib0011","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/s41467-019-09923-2","article-title":"Side chain to main chain hydrogen bonds stabilize polyglutamine helices in transcription factors","volume":"10","author":"Escobedo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.nmd.2019.07.008_bib0012","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.str.2017.11.007","article-title":"Regulation of androgen receptor activity by transient interactions of its transactivation domain with general transcription regulators","volume":"26","author":"De Mol","year":"2018","journal-title":"Struct"},{"key":"10.1016\/j.nmd.2019.07.008_bib0013","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pneurobio.2011.10.003","article-title":"Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases","volume":"97","author":"Sambataro","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0014","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.neuron.2009.07.019","article-title":"Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy","volume":"63","author":"Palazzolo","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2019.07.008_bib0015","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1172\/JCI28773.","article-title":"Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model","volume":"116","author":"Yu","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.nmd.2019.07.008_bib0016","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1152\/japplphysiol.00886.2014","article-title":"Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy","volume":"118","author":"Oki","year":"2015","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.nmd.2019.07.008_bib0017","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00401-016-1550-4","article-title":"Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet","volume":"132","author":"Rocchi","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0018","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mus.21310","article-title":"Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis","volume":"40","author":"Chahin","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2019.07.008_bib0019","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/jnnp.45.11.1012","article-title":"X-linked recessive bulbospinal neuronopathy: a report of ten cases","volume":"45","author":"Harding","year":"1982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2019.07.008_bib0020","first-page":"1087","article-title":"Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients","volume":"26","author":"Borgia","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.008_bib0021","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mus.21310","article-title":"Serum creatine kinase levels in spinobulbar muscular atrophy and amyotrophic lateral sclerosis","volume":"40","author":"Chahin","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2019.07.008_bib0022","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2007.08.012","article-title":"Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females","volume":"264","author":"Soraru","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2019.07.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168846","article-title":"Decreased peak expiratory flow associated with muscle fiber-type switching in spinal and bulbar muscular atrophy","volume":"11","author":"Yamada","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2019.07.008_bib0024","doi-asserted-by":"crossref","first-page":"41046","DOI":"10.1038\/srep41046","article-title":"Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes","volume":"7","author":"Milioto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2019.07.008_bib0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jsbmb.2018.12.005","article-title":"Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists","volume":"188","author":"Roell","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0026","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuron.2014.12.031","article-title":"Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy","volume":"85","author":"Scaramuzzino","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nmd.2019.07.008_bib0027","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1126\/scitranslmed.aam6375","article-title":"Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid alpha-glucosidase","volume":"9","author":"Puzzo","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.nmd.2019.07.008_bib0028","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/15548627.2018.1535292","article-title":"Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration","volume":"15","author":"Rusmini","year":"2019","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.008_bib0029","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13023-018-0918-z","article-title":"The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage","volume":"13","author":"Ambrosini","year":"2018","journal-title":"Orph J Rare Dis."},{"issue":"10","key":"10.1016\/j.nmd.2019.07.008_bib0030","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.nmd.2015.06.462","article-title":"210th ENMC international workshop: research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March 2015, Naarden, the Netherlands","volume":"25","author":"Pennuto","year":"2015","journal-title":"Neuromuscul Disord."},{"issue":"3","key":"10.1016\/j.nmd.2019.07.008_bib0031","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12031-015-0704-5","article-title":"Towards a European Registry and biorepository for patients with spinal and bulbar muscular atrophy","volume":"58","author":"Pareyson","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.nmd.2019.07.008_bib0032","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.nmd.2015.03.008","article-title":"A functional scale for spinal and bulbar muscular atrophy: cross-sectional and longitudinal study","volume":"25","author":"Hashizume","year":"2015","journal-title":"Neuromuscular Disorders"},{"key":"10.1016\/j.nmd.2019.07.008_bib0033","article-title":"Assessing function and endurance in adults with spinal and bulbar muscular atrophy: validity of the adult myopathy assessment tool","author":"Harris-Love","year":"2014","journal-title":"Rehabil Res Pract."},{"key":"10.1016\/j.nmd.2019.07.008_bib0034","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1474-4422(15)00242-2","article-title":"MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study","volume":"15","author":"Morrow","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1136\/jnnp.2006.112532","article-title":"Widespread white matter changes in Kennedy disease: a voxel-based morphometry study","volume":"78","author":"Kassubek","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2019.07.008_bib0036","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hbm.20971","article-title":"Whole brain-based analysis of regional white matter tract alterations in rare motor neuron diseases by diffusion tensor imaging","volume":"31","author":"Unrath","year":"2010","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.nmd.2019.07.008_bib0037","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/ane.12018","article-title":"Structural changes of central white matter tracts in Kennedy's disease - a diffusion tensor imaging and voxel-based morphometry study","volume":"127","author":"Pieper","year":"2013","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nmd.2019.07.008_bib0038","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000084650","article-title":"MR-pathologic comparison of the upper spinal cord in different motor neuron diseases","volume":"53","author":"Sperfeld","year":"2005","journal-title":"Eurol Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0039","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jns.2013.09.016","article-title":"Cerebral involvement in spinal and bulbar muscular atrophy (Kennedy's disease): a pilot study of PET","volume":"335","author":"Lai","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2019.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00415-009-5212-5","article-title":"Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients","volume":"256","author":"Soukup","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0041","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3109\/21678421.2013.837927","article-title":"Minor cognitive disturbances in X-linked spinal and bulbar muscular atrophy, Kennedy's disease","volume":"15","author":"Kasper","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.1016\/j.nmd.2019.07.008_bib0042","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00415-014-7567-5","article-title":"Theory of mind, empathy and neuropsychological functioning in X-linked Spinal and Bulbar Muscular Atrophy: a controlled study of 20 patients","volume":"262","author":"Di Rosa","year":"2015","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0043","doi-asserted-by":"crossref","first-page":"13627","DOI":"10.1038\/s41598-018-32062-5","article-title":"Not impaired neuropsychological performance and enhanced memory recall in patients with SBMA: a large sample comparative study","volume":"8","author":"Marcato","year":"2018","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.nmd.2019.07.008_bib0044","doi-asserted-by":"crossref","first-page":"e95516","DOI":"10.1371\/journal.pone.0095516","article-title":"Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis","volume":"2014","author":"El Mendili","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2019.07.008_bib0045","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/ene.13329","article-title":"Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis","volume":"24","author":"Querin","year":"2017","journal-title":"Eur J Neurol"},{"issue":"11","key":"10.1016\/j.nmd.2019.07.008_bib0046","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1136\/jnnp-2017-317214","article-title":"Multimodal spinal cord MRI offers accurate diagnostic classification in ALS","volume":"89","author":"Querin","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2019.07.008_bib0047","article-title":"Cervical spinal cord atrophy profile in adult SMN1-linked SMA","volume":"11","author":"El Mendili","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2019.07.008_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2018.101618","article-title":"The spinal and cerebral profileof adult spinal-muscular atrophy: a multimodal imaging study","volume":"21","author":"Querin","year":"2019","journal-title":"Neuroimage Clin"},{"issue":"6","key":"10.1016\/j.nmd.2019.07.008_bib0049","doi-asserted-by":"crossref","first-page":"e548","DOI":"10.1212\/WNL.0000000000006887","article-title":"Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessments","volume":"92","author":"Dahlqvist","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nmd.2019.07.008_bib0050","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1038\/s41598-019-41240-y","article-title":"Muscle contractility in spinobulbar muscular atrophy","volume":"9","author":"Dahlqvist","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.nmd.2019.07.008_bib0051","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ana.25345","article-title":"Disease progression and outcome measures in spinobulbar muscular atrophy","volume":"84","author":"Dahlqvist","year":"2018","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.nmd.2019.07.008_bib0052","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1212\/WNL.0000000000002332","article-title":"Two- and 6-minute walk tests assess walking capability equally in neuromuscular diseases","volume":"86","author":"Andersen","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2019.07.008_bib0053","article-title":"Plasma pNfH differentiate SBMA from ALS","volume":"2019","author":"Lombardi","year":"2019","journal-title":"BioRxiv"},{"issue":"5","key":"10.1016\/j.nmd.2019.07.008_bib0054","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41588-019-0422-y","article-title":"Expansion of a recessive intronic AAGGG repeat in the RFC1 gene is a common cause of late-onset ataxia","volume":"51","author":"Cortese","year":"2019","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.nmd.2019.07.008_bib0055","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1212\/WNL.0000000000007097","article-title":"Muscle and not neuronal peripheral biomarkers correlate with clinical severity in spinal and bulbar muscular atrophy","volume":"92","author":"Lombardi","year":"2019","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nmd.2019.07.008_bib0056","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008009","article-title":"Skeletal muscle MRI differentiates SBMA and ALS and correlates with disease severity","volume":"93","author":"Klickovic","year":"2019","journal-title":"Neurology"},{"issue":"3 (2014)","key":"10.1016\/j.nmd.2019.07.008_bib0057","first-page":"255","article-title":"Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy","volume":"82","author":"Tomoo","year":"2014","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.nmd.2019.07.008_bib0058","first-page":"251","article-title":"Head lift exercise improves swallowing dysfunction in spinal and bulbar muscular atrophy","volume":"74","author":"Tomoo","year":"2016","journal-title":"Eur Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0059","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nm878","article-title":"Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"9","author":"Katsuno","year":"2003","journal-title":"Nature Med"},{"key":"10.1016\/j.nmd.2019.07.008_bib0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ana.21540","article-title":"Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy","volume":"65","author":"Banno","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0061","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(10)70182-4","article-title":"Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"9","author":"Katsuno","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0062","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(10)70321-5","article-title":"Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial","volume":"10","author":"Fernandez-Rhodes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0063","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/jnnp-2017-316015","article-title":"Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study","volume":"88","author":"Hashizume","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2019.07.008_bib0064","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1093\/hmg\/ddw073","article-title":"A small-molecule NRF1 and NRF2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy","volume":"25","author":"Bott","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2019.07.008_bib0065","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2119\/molmed.2012.00271","article-title":"Insulin-like growth factor (IGF)-1 administration ameliorates disease manifestations in a mouse model of spinal and bulbar muscular atrophy","volume":"18","author":"Rinaldi","year":"2012","journal-title":"Mol Med"},{"key":"10.1016\/j.nmd.2019.07.008_bib0066","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1474-4422(18)30320-X","article-title":"Safety, tolerability, and preliminary efficacy of an IGF-1 mimetic in patients with spinal and bulbar muscular atrophy: a randomised, placebo-controlled trial","volume":"17","author":"Grunseich","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2019.07.008_bib0067","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/mt.2016.13","article-title":"MiR-298 counteracts mutant androgen receptor toxicity in spinal and bulbar muscular atrophy","volume":"24","author":"Pourshafie","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.nmd.2019.07.008_bib0068","doi-asserted-by":"crossref","first-page":"41046","DOI":"10.1038\/srep41046","article-title":"Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes","volume":"7","author":"Milioto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.nmd.2019.07.008_bib0069","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1212\/WNL.0b013e318295d766","article-title":"Pilot trial of clenbuterol in spinal and bulbar muscular atrophy","volume":"80","author":"Querin","year":"2013","journal-title":"Neurology"},{"issue":"370","key":"10.1016\/j.nmd.2019.07.008_bib0070","doi-asserted-by":"crossref","first-page":"370ra181","DOI":"10.1126\/scitranslmed.aaf9526","article-title":"Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy","volume":"8","author":"Polanco","year":"2016","journal-title":"Sci Transl Med"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619310636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896619310636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:08:36Z","timestamp":1760774916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896619310636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0960896619310636"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2019.07.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"241st ENMC international workshop: Towards a European unifying lab for Kennedy's disease. 15\u201317th February, 2019 Hoofddorp, The\u00a0Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}